Editas market cap
WebJun 28, 2024 · NASDAQ: EDIT Editas Medicine Market Cap $480M Today's Change (4.22%) $0.30 Current Price $7.41 Price as of March 29, 2024, 4:00 p.m. ET Good news for Intellia was viewed as good news for... WebDec 18, 2024 · In comparison, Editas Medicine has a market cap of $1.6 billion. With almost no clinical results to speak of, if Editas was in any other sector, I'd recommend investors stay away until it...
Editas market cap
Did you know?
WebApr 13, 2024 · With the market capitalization of Editas Medicine Inc. currently standing at about $434.20 million, investors are eagerly awaiting this quarter’s results, scheduled for May 02, 2024 – May 08, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Web1 day ago · Market Cap. $410M. Today's Change (-2.58%) -$0.04. Current Price ... Bull-market case: Editas is a player in the most exciting growth trend in healthcare right now: gene-editing therapies. The ...
WebAug 6, 2024 · Here's Why Shares of Editas Medicine and Beam Therapeutics Are Soaring Today The Motley Fool Our Services Premium Services Stock Advisor Our Flagship Service Return 395% S&P Return 115% Rule... WebMay 5, 2024 · In the prior-year period, Editas posted a GAAP net loss of $37.7 million, or $0.69 per share. The average analysts' estimate was for a net loss of $0.73 per share. Editas ended the first quarter ...
WebApr 14, 2024 · EDIT stock opened at $7.65 on Friday. Editas Medicine has a one year low of $6.33 and a one year high of $19.97. The stock has a market cap of $527.62 million, … WebApr 12, 2024 · The company has a market capitalization of $462.79 million, a PE ratio of -2.09 and a beta of 1.86. Editas Medicine ( NASDAQ:EDIT - Get Rating) last posted its quarterly earnings results on Wednesday, February 22nd. The company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.84) by ($0.04).
WebApr 13, 2024 · Emma Reeve Editas Medicine today announced the appointment of current Independent Director Emma Reeve as Chair of the Board. ... (NYSE: DX) is a mortgage …
WebAug 12, 2024 · Editas is also the least expensive by far of these three clinical-stage CRISPR-focused biotech companies. The company's lower market cap could make it a more attractive target if Moderna... bypass trend micro usb blockWebApr 21, 2024 · EDIT-301 for Autologous HSCT in Subjects With Severe Sickle Cell Disease The safety and scientific validity of this study is the responsibility of the study sponsor … bypass trigger in test class salesforceWebFeb 2, 2024 · Editas Medicine Market Cap $462M Today's Change (1.02%) $0.07 Current Price $6.92 Price as of April 6, 2024, 4:00 p.m. ET You’re reading a free article with opinions that may differ from The... clothes kat stratford outfitsWebApr 4, 2024 · Editas Medicine Stock Price Today (NASDAQ: EDIT) Quote, Market Cap, Chart WallStreetZen NASDAQ: EDIT Editas Medicine Inc Stock Add to Watchlist … bypass treatmentWebApr 13, 2024 · CAMBRIDGE, Mass., April 13, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced the appointment of current Independent Director... bypass tray คือWebApr 13, 2024 · Editas Medicine Price Performance EDIT stock opened at $6.36 on Thursday. The stock has a market capitalization of $438.65 million, a P/E ratio of -1.98 and a beta of 1.86. The business has a 50-day moving average of $8.62 and a 200-day moving average of $9.84. clothes kindergarten wordwallWebApr 14, 2024 · Editas Medicine (EDIT Quick Quote EDIT - Free Report) shares soared 20.3% in the last trading session to close at $7.65. The move was backed by solid volume with far more shares changing hands ... bypass trial period software